Latest report

Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics

Steve Poile : May 2, 2012 10:25 AM : Deal type reports, Featured, Reports

This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2007 to early 2012. more »

Comments are closed

Latest partnering news

BMS and Tsinghua University in structural biology research pact

May 15, 2012 : Big Pharma, Bristol-Myers Squibb, partnering

Bristol-Myers Squibb Company and Tsinghua University of Beijing,  announced the formation of a multi-year strategic partnership more »

Menarini licenses rights to Priligy

May 15, 2012 : Big Pharma, licensing, Menarini, partnering

Furiex Pharmaceuticals and Menarini Group announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East more »

 More partnering news


Latest M&A news

Kensey Nash Sued by Investor Over $360 Million DSM Bid

May 14, 2012 : dealtalk, M&A

Kensey Nash, a maker of absorbable cardiac medical devices, was sued by a stockholder contending investors will be shortchanged in a planned $360 million bid from Royal DSM more »

Novartis acquires specialty dermatology company Fougera

May 4, 2012 : Big Pharma, M&A, Novartis

Novartis is buying specialty dermatology generics firm Fougera Pharmaceuticals for $1.525 billion in cash more »

 More M&A news

Latest financing news

OncoMed seeks $115 million IPO

May 15, 2012 : financings

OncoMed offers $115M IPO bet on cancer stem cell work more »

Fresenius in public offering for $1.31 billion

May 14, 2012 : financings

Fresenius successfully completes capital increase more »

 More financing news

Latest Dealtalk

Amag Pharma falls after ending sale talks

May 15, 2012 : dealtalk, M&A

Shares of Amag Pharmaceuticals Inc. sank Thursday, a day after the anemia drug maker said it is no longer considering selling itself more »

Kensey Nash Sued by Investor Over $360 Million DSM Bid

May 14, 2012 : dealtalk, M&A

Kensey Nash, a maker of absorbable cardiac medical devices, was sued by a stockholder contending investors will be shortchanged in a planned $360 million bid from Royal DSM more »

 More dealtalk

Featured reports

Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics

Publication date: May 2012      

Royalty Financing Terms and Agreements

Publication date: May 2012      

Cancer Monoclonal Antibody Partnering Terms and Agreements

Publication date: April 2012      

View all reports

Scorecard

Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:

Partnering

M&A

Financing

Top 50 pharma partnering

Top pharma R&D spend

Deal metrics